Newcastle's Freeman Hospital and Royal Victoria Infirmary hepatology departments manage Hepatitis C patients across the North East, a region historically affected by both injection drug use and occupational HCV exposure in its industrial past. For Newcastle patients facing NHS eligibility restrictions or private treatment costs, Resof L provides the same Ledipasvir+Sofosbuvir cure at dramatically reduced cost.
The North East's economic deprivation — among England's highest — means uninsured private HCV treatment costs are prohibitive for many residents. Generic Resof L at a fraction of brand Harvoni's private pricing ensures no Newcastle patient need forgo curative Hepatitis C treatment for financial reasons.
Visit medshopy.com or WhatsApp +91 82650 41513 for Newcastle supply.
The North East's economic deprivation — among England's highest — means uninsured private HCV treatment costs are prohibitive for many residents. Generic Resof L at a fraction of brand Harvoni's private pricing ensures no Newcastle patient need forgo curative Hepatitis C treatment for financial reasons.
Visit medshopy.com or WhatsApp +91 82650 41513 for Newcastle supply.
Can Hepatitis C treatment be safely managed by a GP or community pharmacy in the UK, or does it always need a hospital specialist?The UK has progressively moved Hepatitis C treatment into community settings. NHS England's HCV elimination programme actively supports community pharmacy-based HCV testing and treatment pathways, allowing pharmacists in some areas to initiate and manage treatment under patient group directions or community prescribing protocols. GPs with appropriate training can also prescribe DAA therapy in some NHS regions. This community-based model is particularly important in North East England where hospital specialist capacity is limited and community pharmacy access is often more convenient for patients — including those with drug dependency who may not readily attend hospital clinics. Newcastle's innovative community HCV treatment programmes have been recognised as models for reaching underserved patient groups.
